Bankrupt Purdue Pitches $5.39M Exec Payment Plan
Purdue Pharma asked a New York bankruptcy court Monday to approve the OxyContin drugmaker's 2021 employee incentive and retention plans, which propose to pay its top five executives up to $5.39...To view the full article, register now.
Already a subscriber? Click here to view full article